The evidence is in: the Surviving Sepsis Campaign saves lives

I first reported outcome based evidence on the effects of the most maligned pharmaceutical industry campaign here. The campaign was associated with increased adherence to evidence based practice and reduction in mortality. Now a review in Clinics in Chest Medicine reports several additional studies confirming the mortality benefit attributable to the influence of the campaign.

For many years the pharmascolds made the completely non-evidence based claim that pharmaceutical industry marketing campaigns were harmful to patients. For almost three years on this blog I asked for evidence concerning the effect of industry campaigns on patient outcomes. Now the evidence is finally coming in, and so far it’s favorable to influence of industry.